Search research articles
Contact Us
Filters
Showing results (1-10 of 121) with videos related to
Page
of 13
Sort By:
Cancer
|
April 8, 2014
Patient-derived sarcoma xenografts for individual-patient selection of chemotherapy--ready for prime time?
Andrew J Wagner
Hematology/Oncology Clinics of North America
|
October 8, 2013
Sarcoma
Andrew J Wagner
Current Opinion in Oncology
|
June 6, 2012
Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumors
Zuzana Tothova, Andrew J Wagner
JAMA Oncology
|
June 8, 2018
Low Levels of Evidence for Neoadjuvant Chemotherapy to Treat Soft-Tissue Sarcoma
Suzanne George, Andrew J Wagner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2012
The challenge of choosing appropriate end points in single-arm phase II studies of rare diseases
Stefan Sleijfer, Andrew J Wagner
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 29, 2010
Specific targets in sarcoma and developmental therapeutics
David M Thomas, Andrew J Wagner
Archives of Pathology & Laboratory Medicine
|
January 11, 2012
Predictors of response to targeted therapies for gastrointestinal stromal tumors
Andrea Marrari, Andrew J Wagner, Jason L Hornick
Orphanet Journal of Rare Diseases
|
October 7, 2023
Supporting patients in the transition to the revised pexidartinib dosing regimen: perspectives from the multidisciplinary clinical and allied health professional team
Colleen McCabe, Hillary Wright, Kathleen Polson, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Targeted therapy in sarcoma: should we be lumpers or splitters?
Richard F Riedel, Robert G Maki, Andrew J Wagner
Angewandte Chemie (International Ed. in English)
|
July 22, 2014
On the rotational intergrowth of hierarchical FAU/EMT zeolites
Maryam Khaleel, Andrew J Wagner, K Andre Mkhoyan, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 121) with videos related to
Sort By:
Page
of 13
Cancer
|
April 8, 2014
Patient-derived sarcoma xenografts for individual-patient selection of chemotherapy--ready for prime time?
Andrew J Wagner
Hematology/Oncology Clinics of North America
|
October 8, 2013
Sarcoma
Andrew J Wagner
Current Opinion in Oncology
|
June 6, 2012
Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumors
Zuzana Tothova, Andrew J Wagner
JAMA Oncology
|
June 8, 2018
Low Levels of Evidence for Neoadjuvant Chemotherapy to Treat Soft-Tissue Sarcoma
Suzanne George, Andrew J Wagner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2012
The challenge of choosing appropriate end points in single-arm phase II studies of rare diseases
Stefan Sleijfer, Andrew J Wagner
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 29, 2010
Specific targets in sarcoma and developmental therapeutics
David M Thomas, Andrew J Wagner
Archives of Pathology & Laboratory Medicine
|
January 11, 2012
Predictors of response to targeted therapies for gastrointestinal stromal tumors
Andrea Marrari, Andrew J Wagner, Jason L Hornick
Orphanet Journal of Rare Diseases
|
October 7, 2023
Supporting patients in the transition to the revised pexidartinib dosing regimen: perspectives from the multidisciplinary clinical and allied health professional team
Colleen McCabe, Hillary Wright, Kathleen Polson, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Targeted therapy in sarcoma: should we be lumpers or splitters?
Richard F Riedel, Robert G Maki, Andrew J Wagner
Angewandte Chemie (International Ed. in English)
|
July 22, 2014
On the rotational intergrowth of hierarchical FAU/EMT zeolites
Maryam Khaleel, Andrew J Wagner, K Andre Mkhoyan, et al.
Page
of 13